The Advisory Committee on Immunization Practices kicks off its December meeting with a full-day focus on the hepatitis B vaccine. The agenda includes presentations from both the Vaccines for Children (VFC) program and CMS, followed by public comment and committee votes. This session could shape hepatitis B vaccination policy heading into 2026.